Missense mutations in SMN2 are enough to abrogate splicing factor arginine/serine-rich 1 (SFRS1/SF2/ASF) binding and promote exon skipping of exon 7 [72] in cases of SMA. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.